Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study

Leuk Lymphoma. 2015 Mar;56(3):770-3. doi: 10.3109/10428194.2014.933216. Epub 2014 Aug 4.

Authors

Sara Bigliardi¹, Monica Morselli, Leonardo Potenza, Valeria Coluccio, Monica Maccaferri, Ambra Paolini, Elisabetta Colaci, Valeria Fantuzzi, Laura Faglioni, Francesco Soci, Vincenzo Nasillo, Andrea Messerotti, Paola Pedrazzi, Marco Marietta, Mario Luppi, Fabio Forghieri

Affiliation

¹ Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico , Modena , Italy.

PMID: 24991716
DOI: 10.3109/10428194.2014.933216

No abstract available

Publication types

Letter

MeSH terms

Adult
Asparaginase / adverse effects
Asparaginase / therapeutic use*
Erwinia / enzymology*
Female
Humans
Male
Middle Aged
Polyethylene Glycols
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
Retrospective Studies
Thrombosis / chemically induced
Young Adult

Substances

Polyethylene Glycols
pegaspargase
Asparaginase